Traditional Chinese medicine composition, traditional Chinese medicine preparation and application

Through traditional Chinese medicine compositions of ginseng, coptis chinensis, small pollen, duckweed and ghost arrow feather, the poor response and drug resistance of Western medicine in the treatment of type 2 diabetes are solved, early blood sugar control and complication delay, and the quality of life of patients is improved.

CN120437218APending Publication Date: 2025-08-08SUZHOU TRADITIONAL CHINESE MEDICINE HOSPITAL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202510788051.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-06-13
Publication Date
2025-08-08

AI Technical Summary

Technical Problem

The current Western medicine for type 2 diabetes has poor response, drug resistance and adverse gastrointestinal reactions in some patients, and lifestyle management is difficult to persist for a long time, which affects the quality of life.

Method used

A Chinese medicine composition of ginseng, coptis chinensis, ceiling pollen, duckweed, and ghost arrow feathers is used to form a new Chinese medicine composition for the treatment of type 2 diabetes, especially in the early stages.

Benefits of technology

Significantly control blood sugar, improve insulin resistance, regulate lipid metabolism, delay complications, and improve patients' quality of life.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN120437218A_ABST
    Figure CN120437218A_ABST
Patent Text Reader

Abstract

The invention relates to a traditional Chinese medicine composition, a traditional Chinese medicine preparation and application. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 6-21 parts of ginseng, 6-21 parts of coptis chinensis, 6-21 parts of radices trichosanthis, 9-30 parts of duckweed and 9-30 parts of euonymus alatus. The traditional Chinese medicine composition provided by the invention can be used for effectively controlling blood sugar, especially treating type 2 diabetes mellitus.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of traditional Chinese medicine, and in particular to a traditional Chinese medicine composition, a traditional Chinese medicine preparation and applications. Background Art

[0002] As the incidence of diabetes continues to rise, it is severely impacting patients' life expectancy and increasing the economic burden. While Western medications and lifestyle management have been widely used in the treatment and control of diabetes, achieving progress in early diabetes prevention, blood sugar control, diabetes remission, cardiorenal protection, and complication prevention, these lifestyles are difficult to maintain long-term. Some patients may experience poor responses or drug resistance to Western medications, while some medications may have adverse reactions, such as those affecting the digestive tract, that affect long-term use. Furthermore, some patients experience decreased blood sugar levels but clinical symptoms do not improve, impacting their quality of life.

[0003] As a vital component of traditional Chinese medicine, Traditional Chinese Medicine (TCM), with its unique theoretical framework and therapeutic approaches, is widely used in the management and treatment of diabetes. As one of the earliest countries to recognize diabetes, ancient texts often referred to diabetes as "xiaoke disease," also known by various names, including diaphragmatic xiao, wind xiao, lung xiao, xiao yan, rezhong, and xiaozhong. Regarding the etiology and pathogenesis of diabetes, physicians throughout history have generally held that "yin deficiency is the root cause, and dryness and heat are the symptoms," with the two being mutually interdependent. Treatments often utilize yin-nourishing and heat-clearing strategies.

[0004] However, with changes in modern lifestyles and dietary patterns, long-term overconsumption of rich, sweet foods can impair the spleen's transport and transformation functions, leading to stagnation in the stomach, heat accumulation, and dryness, resulting in the early stages of diabetes. However, heat, a yang evil, not only easily damages yin and depletes body fluid, resulting in yin deficiency and dryness. The Suwen (Suwen) Yin Yang Ying Xiang Da Lun states that "strong fire consumes qi." Heat also easily depletes qi, leading to symptoms of qi and yin deficiency, such as thirst, polydipsia, fatigue, and listlessness. Furthermore, modern medicine's new understanding of the pathogenesis and pathology of diabetes reveals that in the initial stages of diabetes, sugar toxicity can invade the body's superficial collaterals, causing obstructed blood flow and viscous, stagnant blood, manifesting as "collateral stasis"—a phenomenon that persists throughout the course of diabetes. Therefore, in addition to nourishing yin and clearing heat, early treatment of diabetes should also focus on invigorating qi and activating blood circulation. Summary of the Invention

[0005] The present invention is based on the concept of "preventive treatment" and combines the new progress in diabetes. It gives full play to the characteristics of TCM's diagnosis and treatment based on syndrome differentiation and holistic concept to form a new Chinese medicine composition for treating diabetes. Through the unique combination (ginseng, coptis root, radix trichosanthis, duckweed, and radix sylvestris), it exerts a synergistic effect and has the comprehensive effects of nourishing qi and yin, clearing away heat and dampness, and promoting blood circulation and fluid circulation. It is in line with the treatment principle of nourishing yin and clearing heat, nourishing qi and promoting blood circulation in the early stage of diabetes. Experiments have shown that the composition is effective in controlling blood sugar (especially postprandial blood sugar), improving insulin resistance, regulating lipid metabolism, reducing body weight, and improving clinical symptoms. It shows good comprehensive treatment advantages and provides more optional treatment options for diabetic patients.

[0006] Solutions for solving problems

[0007] The invention provides a traditional Chinese medicine composition for treating diabetes. The composition is prepared from the following raw materials in parts by weight: 6-21 parts of ginseng, 6-21 parts of coptis chinensis, 6-21 parts of trichosanthes, 9-30 parts of duckweed, and 9-30 parts of euphorbia pulex.

[0008] Preferably, the traditional Chinese medicine composition is prepared by comprising the following raw materials in parts by weight: 9-18 parts of ginseng, 9-18 parts of coptis chinensis, 9-18 parts of trichosanthes, 12-21 parts of duckweed, and 12-21 parts of euphorbia pulex.

[0009] Preferably, the traditional Chinese medicine composition is prepared by including the following raw materials in parts by weight: 15 parts of ginseng, 15 parts of coptis chinensis, 15 parts of trichosanthes, 15 parts of duckweed, and 15 parts of euphorbia pulex.

[0010] Preferably, the traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 15 parts of ginseng, 15 parts of coptis chinensis, 15 parts of trichosanthes, 15 parts of duckweed, and 15 parts of euphorbia pulex.

[0011] The present invention provides a traditional Chinese medicine preparation, which comprises any one of the traditional Chinese medicine compositions described above.

[0012] Preferably, the traditional Chinese medicine preparation further comprises a pharmaceutically acceptable carrier.

[0013] The present invention provides a method for preparing a traditional Chinese medicine preparation, wherein the raw medicine in parts by weight described in any one of the above items is added or not added with a pharmaceutically acceptable carrier to prepare a clinically acceptable preparation.

[0014] The present invention provides use of any of the above-mentioned traditional Chinese medicine compositions, the above-mentioned traditional Chinese medicine preparations, or the traditional Chinese medicine preparations prepared according to the above-mentioned preparation methods in the preparation of drugs for treating diabetes;

[0015] Preferably, the diabetes is type 2 diabetes.

[0016] Preferably, the pharmaceutical preparation is an oral preparation.

[0017] Preferably, the oral preparation is selected from one or more of decoctions, powders, capsules, tablets, honey pills, water-honey pills, water pills, concentrated pills, paste pills, wax pills, granules, oral liquids or dripping pills, more preferably decoctions, powders, capsules or oral liquids.

[0018] Effects of the Invention

[0019] The present invention provides a novel traditional Chinese medicine composition for treating type 2 diabetes, comprising ginseng, coptis root, radix trichosanthis, duckweed and feather of the Chinese wolfberry. The whole formula is compatible with the effects of sweet invigorating the body fluid and returning the body fluid, pungent in opening the body fluid and bitter in descending the body, and dispersing and purging the body fluid. It has the effects of invigorating qi and nourishing yin, clearing away heat and removing dampness, and promoting blood circulation and promoting the movement of body fluid. It conforms to the treatment principle of nourishing yin and clearing heat, invigorating qi and promoting blood circulation in the early stage of diabetes, can effectively treat diabetes, especially in the early stage of diabetes, and at the same time delay the occurrence of diabetic complications. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] Figure 1 The fasting blood glucose levels of the Chinese medicine preparations of Examples 1 to 3 of the present invention and the component missing group, wherein A is the fasting blood glucose level of the full prescription groups 1 to 3, and B is the fasting blood glucose level of the full prescription group 3 and the component missing group, wherein, * compared with the model group, P < 0.05; ** compared with the model group, P < 0.01; # compared with the missing group group, P < 0.05;

[0021] Figure 2 These are the fasting insulin levels of the Chinese medicine preparations in Examples 1 to 3 of the present invention and the component-missing group, where A is the fasting insulin level of the full-prescription groups 1 to 3, and B is the fasting insulin level of the full-prescription group 3 and the component-missing group, where * / #, P<0.05, ** / ##, P<0.01. DETAILED DESCRIPTION

[0022] To make the technical solutions and beneficial effects of the present invention more clearly understood, the following is a detailed description by listing specific embodiments. Unless otherwise defined, the technical and scientific terms used herein have the same meanings as those in the technical field to which this application belongs.

[0023] To make the technical solutions and beneficial effects of the present invention more clearly understood, the following is a detailed description by listing specific embodiments. Unless otherwise defined, the technical and scientific terms used herein have the same meanings as those in the technical field to which this application belongs.

[0024] Current modern medical treatments for type 2 diabetes have problems such as some patients responding poorly to conventional treatments or developing drug resistance, some drugs having adverse reactions such as digestive tract effects that affect long-term use, and patients' blood sugar levels dropping but clinical symptoms failing to improve, affecting their quality of life. Based on this, the inventors have discovered through extensive experimental research that they have proposed a novel Chinese medicine composition for the treatment of type 2 diabetes, comprising ginseng, coptis root, radix trichosanthis, duckweed, and plumbaginous plants. Among them, ginseng: sweet, slightly bitter, slightly warm, enters the lung, spleen, heart, and kidney meridians, nourishes the spleen and lungs, promotes fluid production and quenches thirst; Coptis chinensis: bitter and cold, enters the heart, spleen, stomach, liver, gallbladder, and large intestine meridians, clears away heat and dampness, purges fire and detoxifies; Radix Trichosanthis: sweet, slightly bitter, slightly cold, enters the lung and stomach meridians, clears the fire of the lungs and stomach, benefits the yin of the lungs and stomach, and produces fluid in the lungs and stomach; Duckweed: pungent and cold, enters the lung and bladder meridians, relieves fever, promotes diuresis and reduces swelling, treats thirst, promotes fluid production and quenches thirst, and promotes urination; Euonymus: bitter, pungent, and cold, enters the liver and spleen meridians, relieves blood stasis and promotes blood circulation and the distribution of fluid.

[0025] The combination of Radix Trichosanthis and Radix Ginseng nourishes Qi, yin, and fluid, while Rhizoma Coptis chinensis, a bitter and cold herb, clears heat, removes dampness, and strengthens Yin. The combination of these three herbs has the effects of clearing heat, invigorating Qi, promoting fluid production, and quenching thirst, consistent with the "strong fire and qi-eating" pathogenesis of diabetes mellitus. Duckweed promotes diuresis, promotes fluid production, and quenches thirst. A recent randomized cross-controlled clinical study found that duckweed has a potential beneficial effect on controlling postprandial blood sugar, a characteristic of early-stage type 2 diabetes. Herba Glehniae clears blood stasis, promotes fluid circulation, and is a key remedy for the initial stages of diabetes, when sugar toxicity damages the collaterals and causes blood viscosity and stagnation. Modern research also shows that the active ingredients of Herba Glehniae have effective therapeutic effects in lowering blood sugar, improving insulin resistance, protecting pancreatic beta cells, inhibiting a-glucosidase, regulating lipid metabolism disorders, combating oxidative stress, and improving blood rheology. Furthermore, Herba Glehniae has the potential to prevent and treat various chronic diabetic complications, including delaying glomerulosclerosis, protecting renal tubular epithelial cells, protecting myocardial cells, and inhibiting aldose reductase. Therefore, the whole formula is combined with sweet to retain body fluid, pungent to open and bitter to descend, and has the effects of invigorating qi and nourishing yin, clearing away heat and dampness, and promoting blood circulation and promoting the movement of body fluid. It is in line with the treatment principles of nourishing yin, clearing heat, invigorating qi and activating blood circulation in the early stage of diabetes, and can effectively treat diabetes, especially in the early stage of diabetes, and at the same time delay the occurrence of diabetic complications.

[0026] The invention provides a traditional Chinese medicine composition for treating diabetes. The composition is prepared from the following raw materials in parts by weight: 6-21 parts of ginseng, 6-21 parts of coptis chinensis, 6-21 parts of trichosanthes, 9-30 parts of duckweed, and 9-30 parts of euphorbia pulex.

[0027] In certain embodiments, the weight parts of ginseng are 6 parts, 7 parts, 8 parts, 9 parts, 10 parts, 11 parts, 12 parts, 13 parts, 14 parts, 15 parts, 16 parts, 17 parts, 18 parts, 19 parts, 20 parts, 21 parts, etc.

[0028] In certain embodiments, the weight parts of Coptis chinensis are 6 parts, 7 parts, 8 parts, 9 parts, 10 parts, 11 parts, 12 parts, 13 parts, 14 parts, 15 parts, 16 parts, 17 parts, 18 parts, 19 parts, 20 parts, 21 parts, etc.

[0029] In certain embodiments, the weight parts of Radix Trichosanthis are 6 parts, 7 parts, 8 parts, 9 parts, 10 parts, 11 parts, 12 parts, 13 parts, 14 parts, 15 parts, 16 parts, 17 parts, 18 parts, 19 parts, 20 parts, 21 parts, etc.

[0030] In certain embodiments, the weight parts of duckweed are 9 parts, 10 parts, 11 parts, 12 parts, 13 parts, 14 parts, 15 parts, 16 parts, 17 parts, 18 parts, 19 parts, 20 parts, 21 parts, 22 parts, 23 parts, 24 parts, 25 parts, 26 parts, 27 parts, 28 parts, 29 parts, 30 parts, etc.

[0031] In some embodiments, the weight parts of ghost arrow feather are 9 parts, 10 parts, 11 parts, 12 parts, 13 parts, 14 parts, 15 parts, 16 parts, 17 parts, 18 parts, 19 parts, 20 parts, 21 parts, 22 parts, 23 parts, 24 parts, 25 parts, 26 parts, 27 parts, 28 parts, 29 parts, 30 parts, etc.

[0032] In certain embodiments, the traditional Chinese medicine composition is prepared by comprising the following raw materials in parts by weight: 9-18 parts of ginseng, 9-18 parts of coptis chinensis, 9-18 parts of trichosanthes, 12-30 parts of duckweed, and 12-30 parts of euphorbia pulex.

[0033] In certain embodiments, the traditional Chinese medicine composition is prepared by comprising the following raw materials in parts by weight: 12-18 parts of ginseng, 12-18 parts of coptis chinensis, 12-18 parts of trichosanthes, 12-21 parts of duckweed, and 12-21 parts of euphorbia pulex.

[0034] In certain embodiments, the traditional Chinese medicine composition is prepared by comprising the following raw materials in parts by weight: 12-15 parts of ginseng, 12-15 parts of coptis chinensis, 12-15 parts of trichosanthes, 15-18 parts of duckweed, and 15-18 parts of euphorbia pulex.

[0035] In certain embodiments, the traditional Chinese medicine composition is prepared by comprising the following raw materials in parts by weight: 15 parts of ginseng, 15 parts of coptis chinensis, 15 parts of trichosanthes, 15 parts of duckweed, and 15 parts of euphorbia pulex.

[0036] In certain embodiments, the traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 15 parts of ginseng, 15 parts of coptis chinensis, 15 parts of trichosanthes, 15 parts of duckweed, and 15 parts of euphorbia pulex.

[0037] The present invention provides a traditional Chinese medicine preparation, which comprises any one of the traditional Chinese medicine compositions described above.

[0038] In certain embodiments, the traditional Chinese medicine preparation further comprises a pharmaceutically acceptable carrier.

[0039] The present invention provides a method for preparing a traditional Chinese medicine preparation, wherein the raw medicine in parts by weight described in any one of the above items is added or not added with a pharmaceutically acceptable carrier to prepare a clinically acceptable preparation.

[0040] The present invention provides use of any of the above-mentioned traditional Chinese medicine compositions, the above-mentioned traditional Chinese medicine preparations, or the traditional Chinese medicine preparations prepared according to the above-mentioned preparation methods in the preparation of drugs for treating diabetes;

[0041] In certain embodiments, the diabetes is type 2 diabetes.

[0042] In certain embodiments, the pharmaceutical preparation is an oral preparation.

[0043] In certain embodiments, the oral preparation is selected from one or more of decoctions, powders, capsules, tablets, honey pills, water-honey pills, water pills, concentrated pills, paste pills, wax pills, granules, oral liquids or dripping pills, more preferably decoctions, powders, capsules or oral liquids.

[0044] The present invention will be further described below in conjunction with specific examples. It should be understood that these examples are intended to illustrate the present invention and are not intended to limit the scope of the invention. The experimental methods in the following examples, for which no specific conditions are specified, are generally based on conventional conditions or the conditions recommended by the manufacturer. Unless otherwise stated, percentages and parts are by weight.

[0045] Example 1

[0046] A traditional Chinese medicine composition for treating diabetes comprises the following components by weight: 6 parts of ginseng, 6 parts of coptis chinensis, 6 parts of trichosanthes, 9 parts of duckweed, and 9 parts of euphorbia pulex.

[0047] Example 2

[0048] A traditional Chinese medicine composition for treating diabetes comprises the following components by weight: 12 parts of ginseng, 12 parts of coptis chinensis, 12 parts of trichosanthes, 18 parts of duckweed, and 18 parts of euphorbia pulex.

[0049] Example 3

[0050] A traditional Chinese medicine composition for treating diabetes comprises the following components by weight: 15 parts of ginseng, 15 parts of coptis chinensis, 15 parts of trichosanthes, 15 parts of duckweed, and 15 parts of euphorbia pulex.

[0051] Example 4

[0052] A traditional Chinese medicine composition for treating diabetes comprises the following components by weight: 21 parts of ginseng, 21 parts of coptis chinensis, 21 parts of trichosanthes, 30 parts of duckweed, and 30 parts of euphorbia pulex.

[0053] Preparation method and administration: Prepare the raw materials according to the above weight components, mix the raw materials, soak them in a casserole for 30 minutes, add water to cover the medicine, then boil over medium heat until the liquid medicine is about 200 ml and pour it out, add water again to cover the medicine, boil it until about 200 ml of liquid medicine is poured out, mix it with the first liquid medicine, and take it orally twice a day after meals.

[0054] Test Example 1

[0055] The Chinese medicine compositions prepared in Examples 1-4 above were subjected to animal experiments to test the hypoglycemic effect and synergistic effect of the Chinese medicine compositions of the present invention. A key control group was set up, and the specific groups were as follows:

[0056] Full group:

[0057] Whole prescription group 1: Example 1 formula (6 parts of ginseng, 6 parts of coptis root, 6 parts of trichosanthes root, 9 parts of duckweed, 9 parts of euphorbia pulex)

[0058] Whole prescription group 2: Example 2 formula (12 parts of ginseng, 12 parts of coptis root, 12 parts of trichosanthes root, 18 parts of duckweed, 18 parts of euphorbia pulex)

[0059] Whole prescription group 3: Example 3 formula (15 parts of ginseng, 15 parts of coptis root, 15 parts of trichosanthes root, 15 parts of duckweed, 15 parts of euphorbia pulex)

[0060] Whole prescription group 4: Example 4 formula (21 parts of ginseng, 21 parts of coptis root, 21 parts of trichosanthes root, 30 parts of duckweed, 30 parts of euphorbia pulex)

[0061] Missing group grouping:

[0062] Ginseng-deficient group: Example 3 ratio, the formula does not include ginseng (15 parts of Coptis chinensis, 15 parts of Radix Trichosanthis, 15 parts of Lemna edulis, 15 parts of Radix Glehniae)

[0063] Coptis chinensis-deficient group: the ratio of Example 3, but without Coptis chinensis (15 parts of ginseng, 15 parts of trichosanthes, 15 parts of duckweed, and 15 parts of euphorbia pulex)

[0064] Radix Trichosanthis Lack Group: The ratio of Example 3, except that Radix Trichosanthis Lack (15 parts of Radix Ginseng, 15 parts of Coptis chinensis, 15 parts of Lemna edulis, and 15 parts of Euphorbia pulex)

[0065] Duckweed-deficient group: Example 3 ratio, duckweed not included in the formula (15 parts of ginseng, 15 parts of coptis root, 15 parts of trichosanthes root, 15 parts of euphorbia pulex)

[0066] Group lacking Psoralea corylifolia: The ratio of Example 3, but without Psoralea corylifolia (15 parts of ginseng, 15 parts of coptis root, 15 parts of trichosanthes root, and 15 parts of duckweed)

[0067] Grouping and Dosing: Six 7-week-old SPF male db / m mice weighing 20-25g served as a blank control group. Sixty 7-week-old SPF male db / db mice weighing 40-45g were used to establish a successful diabetes model. All 60 db / db mice achieved a successful model with no mortality. They were then randomly assigned to 10 groups of 6 mice each, serving as diabetes model groups and TCM treatment groups. Treatment groups received clinically equivalent doses of the corresponding drugs by gavage (groups were divided into the full formula group and the missing formula group, with different formula ratios calculated based on the amount of the respective raw drugs). The control and model groups received an equal volume of distilled water once daily for 6 weeks.

[0068] Sample Collection and Index Testing: Blood was collected from the tail vein before and 6 weeks after administration, and blood glucose levels were measured using blood glucose test strips. Six weeks after administration, the mice were anesthetized and their eyeballs were removed for blood collection. Blood was stored in blood collection tubes and centrifuged at 3500 rpm for 10 minutes in a low-temperature centrifuge. Serum was separated, aliquoted, and frozen for later use. Fasting insulin levels were measured using an enzyme-linked immunosorbent assay.

[0069] The results of animal experiments showed that mice in the full-prescription group 4 developed adverse reactions such as mental depression, severe constipation, and abdominal distension. Three mice in this group died. The mice in the other groups were in good condition during the experiment, so the full-prescription group 4 was not included in the final statistics.

[0070] Hypoglycemic effect: Figure 1 As shown in Figures A and 1B, after 6 weeks of administration, fasting blood glucose in Group 3 of the full formula was significantly lower than that in the model group (P < 0.01) and also significantly lower than that in the missing group (P < 0.05). The hypoglycemic effect of Example 3 (Full Formula Group 3) was superior to that of Examples 1 and 2, indicating that the optimal ratio of Example 3 (Full Formula Group 3) was the most effective.

[0071] Insulin levels: e.g. Figure 2 As shown in Figures A and 2B, after 6 weeks of administration, fasting insulin levels in the full formula group were significantly lower than in the model group (P < 0.01). Compared with the group missing the formula, the full formula group also had significantly lower insulin levels (P < 0.05), demonstrating that the components of the Chinese herbal composition of the present invention are essential and synergistic in improving insulin sensitivity. Example 3 (full formula group 3) showed the best effect in improving insulin levels.

[0072] Test Example 2

[0073] Based on the results of animal experiments, we conducted clinical efficacy observation tests on the Chinese medicine compositions of Examples 2 and 3:

[0074] Study subjects: 24 newly diagnosed type 2 diabetes patients aged 30-65 years were enrolled in outpatient or hospitalized patients, including 13 males and 11 females. The patients were divided into three groups:

[0075] Treatment group 1: 8 cases, given the Chinese medicine decoction of Example 2 (12 parts of ginseng, 12 parts of coptis root, 12 parts of trichosanthes root, 18 parts of duckweed, and 18 parts of euphorbia pulex)

[0076] Treatment group 2: 8 cases, given the Chinese medicine decoction of Example 3 (15 parts of ginseng, 15 parts of coptis root, 15 parts of trichosanthes root, 15 parts of duckweed, 15 parts of euphorbia pulex)

[0077] Control group: 8 cases, given saxagliptin tablets.

[0078] Treatment options:

[0079] Basic treatment: standard lifestyle, dietary intervention and exercise intervention (throughout the entire trial period).

[0080] Group treatment:

[0081] Treatment group 1: Based on the lifestyle intervention, the patients were orally administered the decoction of the Chinese medicinal composition of Example 2 of the present invention, 1 dose per day, decocted in water, taken in the morning and evening, for a course of 3 months.

[0082] Treatment group 2: Based on the lifestyle intervention, the patients were orally administered the decoction of the Chinese medicinal composition of Example 3 of the present invention, 1 dose per day, decocted in water, taken in the morning and evening, for a course of 3 months.

[0083] Control group: Oral saxagliptin tablets, 5 mg each time, once a day, for 3 months based on lifestyle intervention;

[0084] Evaluation indicators:

[0085] Clinical efficacy evaluation: Markedly effective: The patient's symptoms such as dry mouth, polydipsia, and fatigue were significantly improved, fasting blood sugar was controlled within the normal range, and blood sugar 2 hours after a meal was controlled within the normal range; Effective: The patient's symptoms such as dry mouth, polydipsia, and fatigue were alleviated, fasting blood sugar decreased significantly compared with before but not to the normal range, and blood sugar 2 hours after a meal decreased significantly compared with before but not to the normal range; Ineffective: The patient's symptoms such as dry mouth, polydipsia, and fatigue did not change and / or fasting blood sugar and blood sugar 2 hours after a meal did not decrease significantly.

[0086] The Traditional Chinese Medicine (TCM) symptom scoring method conforms to the diagnostic criteria for Qi and Yin deficiency in diabetes as outlined in the "Guidelines for the Prevention and Treatment of Diabetes with Traditional Chinese Medicine." Primary symptoms include dry throat and mouth, thirst and polydipsia, and fatigue. Secondary symptoms include shortness of breath, laziness, soreness of the waist and knees, spontaneous sweating, night sweats, restlessness, palpitations, and insomnia. Tongue and pulse: red tongue with little fluid, thin, dry, or white fur, and a thready, rapid pulse. Scoring is based on primary symptoms, with a score of 0 for normal, 2 for mild, 4 for moderate, and 6 for severe. Secondary symptoms are scored as follows: 0 for normal, 1 for mild, 2 for moderate, and 3 for severe.

[0087] Blood glucose levels before and after treatment (fasting and 120 min after oral administration of 82.5 g glucose containing 1 molecule of water) were measured using an automatic biochemical analyzer.

[0088] The levels of total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) before and after treatment were measured using an automatic biochemical analyzer.

[0089] BMI = body mass (kg) / height (m) 2 .

[0090] Study Results

[0091] The results of clinical efficacy evaluation before and after treatment of three groups of type 2 diabetes patients are shown in Table 1. Among them, the total effective rate of treatment group 2 (Example 3) was the highest (87.5%), which was significantly higher than that of the control group (50.0%). The total effective rate of treatment group 1 (Example 2) was 62.5%, which was higher than that of the control group but lower than that of treatment group 2 (Example 3).

[0092] Table 1 Clinical efficacy evaluation results after treatment

[0093]

[0094] The effect of treatment on blood glucose in patients with type 2 diabetes is shown in Table 2. The blood glucose levels of the three groups 120 minutes after treatment were significantly lower than those before treatment (P<0.05). The blood glucose levels of treatment groups 1 and 2 were lower than those of the control group at all time points after treatment. In particular, treatment group 2 was significantly better than the control group in lowering blood glucose levels 120 minutes after a meal (P<0.05).

[0095] Table 2 Effects of treatment on blood glucose in patients with type 2 diabetes ( mmol / L)

[0096]

[0097] *P<0.05, compared with the same group before treatment; #P<0.05, compared with the control group after treatment

[0098] The effect of treatment on the TCM symptom scores of patients is shown in Table 3. After treatment, the TCM symptom scores of treatment groups 1 and 2 were significantly decreased compared with those before treatment and the control group (P<0.05). In particular, the improvement in treatment group 2 was much greater than that in the control group and was also better than that in treatment group 1.

[0099] Table 3 Effects of treatment on patients' TCM symptom scores

[0100]

[0101] *P<0.05, compared with the same group before treatment; #P<0.05, compared with the control group after treatment

[0102] The effects of treatment on lipid metabolism indicators and BMI of patients in each group are compared in Table 4. Treatment group 2 was significantly better than the control group in reducing TC (P<0.05); treatment groups 1 and 2 were significantly better than the control group in improving BMI (P<0.05), and the BMI decrease in treatment group 2 was greater before and after treatment.

[0103] Table 4 Effects of treatment on lipid metabolism indicators and BMI changes in patients with type 2 diabetes

[0104]

[0105]

[0106] *P<0.05, compared with the same group before treatment; #P<0.05, compared with the control group after treatment

[0107] It should be understood that the above embodiments are exemplary and are not intended to encompass all possible implementations of the claims. Various modifications and variations may be made to the above embodiments without departing from the scope of this disclosure. Similarly, the various technical features of the above embodiments may be arbitrarily combined to form additional embodiments of the present invention that may not be explicitly described. Therefore, the above embodiments merely illustrate several implementations of the present invention and do not limit the scope of protection of the patent of this invention.

Claims

1. A Chinese medicine composition for treating diabetes, characterized in that: The traditional Chinese medicine composition comprises the following raw materials in parts by weight: 6-21 parts of ginseng, 6-21 parts of coptis root, 6-21 parts of trichosanthes root, 9-30 parts of duckweed, and 9-30 parts of euphorbia pulex.

2. The Chinese medicine composition according to claim 1, characterized in that The traditional Chinese medicine composition comprises the following raw materials in parts by weight: 9-18 parts of ginseng, 9-18 parts of coptis chinensis, 9-18 parts of trichosanthes, 12-21 parts of duckweed, and 12-21 parts of euphorbia pulex.

3. The Chinese medicine composition according to claim 2, characterized in that The traditional Chinese medicine composition comprises the following raw materials in parts by weight: 15 parts of ginseng, 15 parts of coptis chinensis, 15 parts of trichosanthes, 15 parts of duckweed, and 15 parts of euphorbia pulex.

4. The Chinese medicine composition according to any one of claims 1 to 3, characterized in that The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 15 parts of ginseng, 15 parts of coptis chinensis, 15 parts of trichosanthes, 15 parts of duckweed, and 15 parts of euphorbia pulex.

5. A Chinese medicine preparation, characterized in that The traditional Chinese medicine preparation comprises the traditional Chinese medicine composition according to any one of claims 1 to 4.

6. The Chinese medicine preparation according to claim 5, characterized in that The traditional Chinese medicine preparation also includes a pharmaceutically acceptable carrier.

7. A method for preparing a Chinese medicine preparation, characterized in that: The bulk drug according to any one of claims 1 to 4, in parts by weight, with or without a pharmaceutically acceptable carrier, is prepared into a clinically acceptable preparation.

8. Use of the traditional Chinese medicine composition according to any one of claims 1 to 4, the traditional Chinese medicine preparation according to claim 5 or 6, or the traditional Chinese medicine preparation prepared by the preparation method according to claim 7 in the preparation of a medicament for treating diabetes; Preferably, the diabetes is type 2 diabetes.

9. The use according to claim 8, characterized in that The preparation of the medicine is an oral preparation.

10. The use according to claim 9, characterized in that The oral preparation is selected from one or more of decoctions, powders, capsules, tablets, honey pills, water-honey pills, water pills, concentrated pills, paste pills, wax pills, granules, oral liquids or dripping pills, more preferably decoctions, powders, capsules or oral liquids.